AIM ImmunoTech is trading 5.69% up now at $0.23 after closing August 14, 2026 at $0.22, with no clear company-specific catalyst identified for the after-hours move.

  • Its latest notable update was the August 10 second-quarter report.
  • The report showed a $3.8 million net loss and weaker-than-expected EPS.
  • That news predates the move and does not clearly explain the after-hours rebound.